VALUE ADDED MEDICINES ONLINE SUMMIT Empowering the healthcare community by improving existing treatments

Biosimilar Medicine Market Review 2020

Market Review – European Generic Medicine Markets 2020

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

COVID-19 “Round 2” – Findings & way forward (Kearney)

Why is Now the Right Time to Modernise the Eu Variations System?

AMR Industry Alliance 2020 Progress Report

Perceptions and recommendations of physicians/KOLs on value added medicines